Biotech · Private company
Faron Pharmaceuticals Ltd
Track this companyFree. Adds Faron Pharmaceuticals Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs9From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline9
- azacitidinePhase 2 · Higher Risk Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- BexmarilimabPhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- bexmarilimab (1mg/kg)Phase 2 · Higher Risk Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- bexmarilimab (3mg/kg)Phase 2 · Higher Risk Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- FP-1305 (bexmarilimab)Phase 2 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- IFN beta-1aPhase 2 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- VenetoclaxPhase 2 · Acute Myeloid LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic SyndromesPHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07672769 · fetched Nov 12, 2026
- Interferon-Beta-1a (FP-1201) to Prevent Toxicities After CD19-Directed CAR T-Cell TherapyPHASE1_PHASE2 · WITHDRAWN · started Apr 1, 2025ClinicalTrials.gov NCT05936229 · fetched Nov 12, 2026
- Dose Escalation Trial of Bexmarilimab (FP-1305) Plus Pembrolizumab in Non-Small Cell Lung CancerPHASE1 · WITHDRAWN · started Jun 1, 2023ClinicalTrials.gov NCT05171062 · fetched Nov 12, 2026
- A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological MalignanciesPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 2, 2022ClinicalTrials.gov NCT05428969 · fetched Nov 12, 2026
- Human Intravenous Interferon Beta-Ia Safety and Preliminary Efficacy in Hospitalized Subjects With COVID-19PHASE2 · TERMINATED · started Aug 23, 2021ClinicalTrials.gov NCT04860518 · fetched Nov 12, 2026
- A Study to Evaluate Safety, Tolerability and Preliminary Efficacy of FP-1305 in Cancer Patients (MATINS)PHASE1_PHASE2 · COMPLETED · started Dec 3, 2018ClinicalTrials.gov NCT03733990 · fetched Nov 12, 2026